ClinicalTrials.gg
RecruitingNCT05726578Updated May 28, 2025

Integrated Echocardiography and Chest Ultrasound Assessment of Lung Recruitment in Preterm Infants

An interventional study of Lung recruitment in Ventilator Lung, Echocardiography and Chest Ultrasound, sponsored by Alexandria University. Recruiting at 2 sites in Egypt. Open to participants aged 1 Hour to 3 Days. Per ClinicalTrials.gov, last updated 2025-05-28.

Sponsored by Alexandria University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Not applicable
Ages
1 Hour to 3 Days
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Premature Birth by Alexandria University — 5 open to participants now, 5 under way, none of them phase 3. Premature Birth · Alexandria University.

Planned enrollment
8th of 10
72 · median 100
Started
2024
with 2 others
No phase
8 of 10
5 open now
Registered
5th of 10
by date

Among the 10 studies in Premature Birth by Alexandria University, this one is the 8th largest by planned enrollment, is one of 3 that started in 2024, is one of 8 with no phase, and was the 5th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

5 of the 10 studies in Premature Birth by Alexandria University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 1 Hour to 3 Days · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Premature Birth by Alexandria University, or all of them as a file.
02

Study summary

The primary aim of this work is to evaluate the role of high frequency oscillatory ventilation (HFOV) in recruitment of lung in preterm newborns 32 to 37 weeks gestational age with moderate to severe respiratory distress. The secondary aim is to evaluate the role of chest ultrasound in monitoring of lung recruitment in comparison to routine chest x ray in those babies. Also cardiac hemodynamics will be assesed using functional echocardiography.

03

Conditions studied

  • Ventilator Lung
  • Echocardiography
  • Chest Ultrasound
  • High Frequency Ventilation
  • Lung Recruitment

Browse trials for

Keywords

  • Premature infants
04

Who can participate

Ages eligible
1 Hour to 3 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants will be enrolled if they are 32 to 37 weeks of gestational age, have respiratory distress (RD) in the first 24 h of life, intubated and have invasive respiratory support using HFOV. Signs of RD are tachypnea (respiratory rate > 60/min), grunting, nasal flaring, chest retraction, and need of oxygen supplementation or other respiratory support.

Exclusion criteria

Exclusion Criteria:

  1. Known major congenital anomalies including congenital heart diseases.
  2. Fetal hydrops.
  3. Babies with congenital heart diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Lung recruitment

    preterm infants with moderate to severe respiratory distress

    Other: Lung recruitment

Interventions

  • OtherLung recruitment

    establishment of lung recruitment using high frequency ventilation and assessment with chest ultrasound and echocardiography

06

What researchers measure

Primary outcomes

  1. chest US

    A mobile device (PHILIPS ® HD11 XE) with a 10-MHz linear probe will be used for chest ultrasound the 12 lung zones will be assessed regarding 1. presence Of A lines, B-lines or C-profile 2. presence or absence of pleural sliding

    Time frame: first 3 days after birth

  2. Superior Vena Cava flow in ml/kg/min

    Superior Vena Cava (SVC) Blood Flow using functional echocardiography

    Time frame: first 3 days of life

  3. estimated pulmonary artery pressure in mmHg

    Pulmonary artery pressure (PAP) will be assessed by measuring tricuspid valve regurgitation peak velocity: this will be measured in apical 4 chamber view, with continous wave Doppler using modified Bernoulli equation. Systolic pulmonary artery pressure is equivalent to right ventricular systolic pressure in absence of outflow obstruction. Systolic Pulmonary Artery Pressure (SPAP) = Right Ventricular Systolic Pressure = 4x TR2 + Right Atrial Pressure (RAP), with RAP= 3-5 mmHg.

    Time frame: first 3 days of life

07

Study locations

1 of 2 sites recruiting
  • Marwa Mohamed Farag
    Alexandria, 0325, Egypt
    Recruiting
  • Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.
    Alexandria, 21131, Egypt
    Not yet recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Jul 2025, 12 months after the start.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 12 months is below that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2023
First posted
Feb 14, 2023
StartActual
Jul 1, 2024
Primary completionEst.
Jul 1, 2025
CompletionEst.
Jul 1, 2025
Last update
May 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05726578
Responsible party
Marwa Mohamed Farag (Primary Investigator and Lecturer in Pediatrics, Faculty of Medicine, Alexandria University) — Principal investigator
First posted
Feb 14, 2023
Start date
Jul 1, 2024
Primary completion
Jul 1, 2025 (estimated)
Completion
Jul 1, 2025 (estimated)
Last update
May 28, 2025

Study contacts

Marwa M Farag, PhD
Contact
d.marwa.farag@gmail.com
01288681788 ext. +2
Mohamed Hany Saad, MBBCh
Contact
mohamedhany_90@icloud.com
01282226826 ext. +2
Mohamed Hazem Wagih Gouda, PhD
study chair · Alexandria University
Ali Mohamed Abd Almohsen, PhD
study director · Alexandria University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion